Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16295 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Cosmin Trif und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cell Signalling Research Group, Institute of Biochemistry of the Romanian Academy, Bucharest, Romania. Hauptthemen laut MEDLINE: Calcium, TRPM Cation Channels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background and Purpose The TRPM8 ion channel is involved in innocuous cold sensing and has a potent anti‐inflammatory action. Its activation by lower temperature or chemical agonists such as menthol and icilin induces analgesic effects, reversing hypersensitivity and reducing chronic pain. On the other hand, prostacyclin (PGI 2 ) enhances pain and inflammation by activating the IP receptors. Due to the critical roles of TRPM8 and IP receptors in the regulation of inflammatory pain, and considering their overlapping expression pattern, we analysed the functional interaction between human TRPM8 and IP receptors. Experimental Approach We transiently expressed human TRPM8 channels and IP receptors in HEK293T cells and carried out intracellular calcium and cAMP measurements. Additionally, we cultured neurons from the dorsal root ganglia (DRGs) of mice and determined the increase in intracellular calcium triggered by the TRPM8 agonist, icilin, in the presence of the IP receptor agonist cicaprost, the IP receptor antagonist Cay10441, and the Gq/11 inhibitor YM254890. Key Results Activation of IP receptors by selective agonists (cicaprost, beraprost, and iloprost) inhibited TRPM8 channel function, independently of the Gs‐cAMP pathway. The potent inhibition of TRPM8 channels by IP receptor agonists involved Gq/11 coupling. These effects were also observed in neurons isolated from murine DRGs. Conclusions and Implications Our results demonstrate an unusual signalling pathway of IP receptors by coupling to Gq/11 proteins to inhibit TRPM8 channel function. This pathway may contribute to a better understanding of the role of TRPM8 channels and IP receptors in regulating pain and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Signalling Research Group, Institute of Biochemistry of the Romanian Academy, Bucharest, Romania.
- Department of Anatomy, Physiology, and Biophysics, Faculty of Biology, University of Bucharest, Bucharest, Romania.
- Institute of Clinical Pharmacology, Pharmazentrum Frankfurt/ZAFES, University Hospital, Goethe-University, Frankfurt am Main, Germany.
- Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
- Prothanor Biotech S.R.L., Bucharest, Romania.
ORCID-Profile: Marco Sisignano, Sorin Tunaru
Zitieren
APA
Trif, C., Banica, A. M., Manolache, A., Anghel, S. A., Huţanu, D. E., Stratulat, T., Badea, R., Oprita, G., Selescu, T., Petrescu, S. M., Sisignano, M., Offermanns, S., Babes, A., & Tunaru, S. (2024). Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins. British Journal of Pharmacology. https://doi.org/10.1111/bph.16295
Vancouver
Trif C, Banica AM, Manolache A, Anghel SA, Huţanu DE, Stratulat T, et al. Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins. British Journal of Pharmacology. 2024. doi:10.1111/bph.16295
BibTeX
@article{Trif2024,
author = {Trif, Cosmin and Banica, Alexandra-Maria and Manolache, Alexandra and Anghel, Sorina Andreea and Huţanu, Debora-Elena and Stratulat, Teodora and Badea, Rodica and Oprita, George and Selescu, Tudor and Petrescu, Stefana M and Sisignano, Marco and Offermanns, Stefan and Babes, Alexandru and Tunaru, Sorin},
title = {Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16295}
}
EUVIMED